On October 28, international fragrance and flavor giant Symrise released its financial results for the third quarter of 2025.
According to the data, in the third quarter, Symrise’s sales reached €1.223 billion, with organic growth of 1.4%; for the first nine months, its sales totaled €3.776 billion, with organic growth of 2.6%.
In this regard, Jean-Yves Parisot, Chief Executive Officer of Symrise, stated that the group’s transformation process continues to gain strong momentum. The company is now accelerating actions to open a new chapter of development and has made clear strategic choices on how to “win in the market and create value” — focusing on growth opportunities, driving differentiated innovation, and optimizing supply chain and sales and marketing operations to better serve customers.
It is understood that Symrise currently has two main business segments: Taste, Nutrition & Health, and Scent & Care. The latter includes three divisions — Fragrance, Cosmetic Ingredients, and Aroma Molecules. In the third quarter, the Scent & Care business achieved sales of €473 million, with organic growth of 1.7%.
Specifically, in the third quarter, the Fragrance division achieved mid-single-digit organic growth; the Cosmetic Ingredients division achieved low-single-digit organic growth, marking its first organic growth this year; while the Aroma Molecules division faced both price and volume pressures due to intensified competition in Asia and overall market volatility, resulting in a lower growth rate compared with the same period last year.
By region, in the third quarter, Symrise’s sales in the Asia-Pacific region reached €250 million, with organic growth of 1.0%. Europe, Africa, and the Middle East recorded an increase of 4.5%, while North America and Latin America saw declines of 1.1% and 1.8%, respectively.
Symrise also mentioned in its financial report that consumer demand remains weak in several markets, and the tariff impact faced by consumers is unlikely to reverse in the short term. Considering these factors, the company has lowered its organic sales guidance from the previous 3.0%–5.0% to 2.3%–3.3%, while maintaining its annual cost-saving target of €40 million to cope with the increasingly challenging macroeconomic environment.
